Morris, David

Sunnybrook Health Science Centre · Institut Gustave Roussy · Urology Associates · Institut Català d'Oncologia · Instituto de Investigación Biomédica de Málaga · Ottawa Hospital Research Institute

2 papers on CoChatORCID 0000-0001-9054-6899

Most cited papers

Verified
Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
Fizazi, K., Piulats, J. M., Reaume, M. N., Ostler, P., McDermott, R., Gingerich, J. R., Pintus, E., Sridhar, S. S., Bambury, R. M., Emmenegger, U., et al. (2023) · New England Journal of Medicine
Prostate Cancer Treatment and ResearchPARP inhibition in cancer therapy
Cited by 449
Verified
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
Chi, K. N., Rathkopf, D., Smith, M. R., Efstathiou, E., Attard, G., Olmos, D., Lee, J. Y., Small, E. J., Pereira de Santana Gomes, A. J., Roubaud, G., et al. (2023) · Journal of Clinical Oncology
Prostate Cancer Treatment and ResearchPARP inhibition in cancer therapy
Cited by 355

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free